[1] | Bouckenooghe T, Remacle C, Reusens B. Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care2006 Nov;9(6):728-33. |
[2] | Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J Nutr2006 Jun;136(6 Suppl):1636S-40S. |
[3] | Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willoughby SR. Detrimental effects of energy drink consumption on platelet and endothelial function. Am J Med2010 Feb;123(2):184-7. |
[4] | Matsuzaki Y, Miyazaki T, Miyakawa S, Bouscarel B, Ikegami T, Tanaka N. Decreased taurine concentration in skeletal muscles after exercise for various durations. Med Sci Sports Exerc2002 May;34(5):793-7. |
[5] | Pierno S, De Luca A, Camerino C, Huxtable RJ, Camerino DC. Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. J Pharmacol Exp Ther1998 Sep;286(3):1183-90. |
[6] | Yatabe Y, Miyakawa S, Miyazaki T, Matsuzaki Y, Ochiai N. Effects of taurine administration in rat skeletal muscles on exercise. J Orthop Sci2003;8(3):415-9. |
[7] | Lev EI, Arikan ME, Vaduganathan M, Alviar CL, Tellez A, Mathuria N, Builes A, Granada JF, del Conde I, Kleiman NS. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease. Am Heart J2007 Oct;154(4):694 e1-7. |
[8] | Chesney RW. Taurine: its biological role and clinical implications. Adv Pediatr1985;32:1-42. |
[9] | Huxtable RJ. Physiological actions of taurine. Physiol Rev1992 Jan;72(1):101-63. |
[10] | Birdsall TC. Therapeutic applications of taurine. Altern Med Rev1998 Apr;3(2):128-36. |
[11] | Guizouarn H, Motais R, Garcia-Romeu F, Borgese F. Cell volume regulation: the role of taurine loss in maintaining membrane potential and cell pH. J Physiol2000 Feb 15;523 Pt 1:147-54. |
[12] | Gordon RE, Park E, Laskin D, Schuller-Levis GB. Taurine protects rat bronchioles from acute ozone exposure: a freeze fracture and electron microscopic study. Exp Lung Res1998 Sep-Oct;24(5):659-74. |
[13] | Gurujeyalakshmi G, Wang Y, Giri SN. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. J Pharmacol Exp Ther2000 Apr;293(1):82-90. |
[14] | Militante JD, Lombardini JB. Taurine: evidence of physiological function in the retina. Nutr Neurosci2002 Apr;5(2):75-90. |
[15] | Pasantes-Morales H, Quiroz H, Quesada O. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis2002 Sep;17(3):183-97. |
[16] | Das J, Ghosh J, Manna P, Sil PC. Taurine provides antioxidant defense against NaF-induced cytotoxicity in murine hepatocytes. Pathophysiology2008 Oct;15(3):181-90. |
[17] | Green TR, Fellman JH, Eicher AL, Pratt KL. Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochim Biophys Acta1991 Jan 23;1073(1):91-7. |
[18] | Gurer H, Ozgunes H, Saygin E, Ercal N. Antioxidant effect of taurine against lead-induced oxidative stress. Arch Environ Contam Toxicol2001 Nov;41(4):397-402. |
[19] | Sinha M, Manna P, Sil PC. Taurine protects the antioxidant defense system in the erythrocytes of cadmium treated mice. BMB Rep2008 Sep 30;41(9):657-63. |
[20] | Zhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids2004 Jun;26(3):267-71. |
[21] | Hoffbrand AV. Essential Haematology: Platelets, Blood coagulation and haemostasis. third ed: Austraia: Blackwell Science; 1993. |
[22] | A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. [Clinical Trial Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 1996 Nov 16;348(9038):1329-39. |
[23] | Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. [Review]. 2003 Jul;26(7):2181-8. |
[24] | Hoffbrand AV. Postgraduate Haematology. 5th ed: USA: Blackwell Publishing; 2005. |
[25] | Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 2003 Jan 28;107(3):398-404. |
[26] | Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest. [Review]. 2004 Feb;113(3):340-5. |
[27] | Quin M. FD, Cox D. Platelet Function: Assesment, Diagnosis, and Treatment: USA: Human Press; 2005. |
[28] | Lepantalo A, Virtanen KS, Resendiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor. Thrombosis research. [Research Support, Non-U.S. Gov't]. 2009 Jun;124(2):193-8. |
[29] | Miglis M, Wilder D, Reid T, Bakaltcheva I. Effect of taurine on platelets and the plasma coagulation system. Platelets. [Research Support, U.S. Gov't, Non-P.H.S.]. 2002 Feb;13(1):5-10. |
[30] | AH G. Platelet-asociated molecules and immunoglobulins.: Blackwell Scientific Publications, Oxford; 1994. |
[31] | Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 1987 Jul;70(1):307-15. |
[32] | Hansen TN, Brockbank KG. Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists. Transfusion. [Research Support, U.S. Gov't, Non-P.H.S.]. 1997 Jul;37(7):696-702. |
[33] | Michelson AD. Flow cytometry: a clinical test of platelet function. Blood. [Review]. 1996 Jun 15;87(12):4925-36. |
[34] | Mutanen M. Cis-unsaturated fatty acids and platelet function. Prostaglandins Leukot Essent Fatty Acids. [Review]. 1997 Oct;57(4-5):403-10. |
[35] | Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ. Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. American heart journal. [Research Support, Non-U.S. Gov't]. 1998 Sep;136(3):398-405. |
[36] | Michelson AD. Platelets. 2nd ed: USA: Academic Press; 2006. |